Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
DarioHealth Corp (DRIO)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: DRIO (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
4 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $2.38
1 Year Target Price $2.38
| 3 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -61.45% | Avg. Invested days 27 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/30/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 29.79M USD | Price to earnings Ratio - | 1Y Target Price 2.38 |
Price to earnings Ratio - | 1Y Target Price 2.38 | ||
Volume (30-day avg) 4 | Beta 1.59 | 52 Weeks Range 0.50 - 1.55 | Updated Date 06/30/2025 |
52 Weeks Range 0.50 - 1.55 | Updated Date 06/30/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.55 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -159.8% | Operating Margin (TTM) -139.35% |
Management Effectiveness
Return on Assets (TTM) -24.04% | Return on Equity (TTM) -59.05% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 32967368 | Price to Sales(TTM) 1.06 |
Enterprise Value 32967368 | Price to Sales(TTM) 1.06 | ||
Enterprise Value to Revenue 1.18 | Enterprise Value to EBITDA -0.59 | Shares Outstanding 44463800 | Shares Floating 35486523 |
Shares Outstanding 44463800 | Shares Floating 35486523 | ||
Percent Insiders 22.06 | Percent Institutions 22.21 |
Analyst Ratings
Rating 2 | Target Price 2.38 | Buy - | Strong Buy 3 |
Buy - | Strong Buy 3 | ||
Hold 1 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
DarioHealth Corp
Company Overview
History and Background
DarioHealth Corp. was founded in 2011 and initially focused on glucose monitoring solutions. It has since evolved into a comprehensive digital health platform addressing multiple chronic conditions.
Core Business Areas
- Chronic Condition Management Platform: DarioHealth's primary offering is a digital health platform that integrates connected medical devices, personalized coaching, and behavioral interventions to manage chronic conditions like diabetes, hypertension, weight management, and behavioral health.
- Enterprise Solutions: DarioHealth provides its platform and services to employers, health plans, and providers, enabling them to offer comprehensive chronic condition management solutions to their members and patients.
- Direct-to-Consumer (DTC): DarioHealth offers its platform and services directly to consumers through online channels.
Leadership and Structure
Erez Raphael is the CEO. The company has a board of directors and operates with functional departments such as product development, marketing, sales, and operations.
Top Products and Market Share
Key Offerings
- Dario Blood Glucose Monitoring System: A smart glucose meter connected to a mobile app for real-time data tracking, personalized insights, and coaching. Competitors include Dexcom (DXCM) and Abbott (ABT). Revenue is embedded in the overall platform revenue, not disaggregated.
- Dario Hypertension Management: A digital hypertension management solution with a connected blood pressure monitor, personalized coaching, and medication adherence support. Competitors include Omron Healthcare and Withings. Revenue is embedded in the overall platform revenue, not disaggregated.
- Dario Weight Management: A comprehensive weight management program featuring personalized coaching, nutrition tracking, and behavioral support. Competitors include WeightWatchers (WW) and Noom. Revenue is embedded in the overall platform revenue, not disaggregated.
- Dario Behavioral Health: A digital behavioral health solution that addresses mental health concerns using various therapeutic practices. Competitors include Teladoc (TDOC) and Talkspace (TALK). Revenue is embedded in the overall platform revenue, not disaggregated.
Market Dynamics
Industry Overview
The digital health market is rapidly growing, driven by increasing prevalence of chronic diseases, rising healthcare costs, and advancements in technology. The market is highly competitive.
Positioning
DarioHealth is positioned as a comprehensive digital health platform focusing on multiple chronic conditions, offering personalized and data-driven interventions. The company aims to differentiate itself through its integrated platform and user-centric approach.
Total Addressable Market (TAM)
The digital health market is expected to reach hundreds of billions of dollars. DarioHealth is positioning itself to capture a significant share of the chronic disease management segment of the TAM. Specific TAM for their targeted conditions are in the billions.
Upturn SWOT Analysis
Strengths
- Comprehensive digital health platform
- Integrated connected devices and personalized coaching
- Data-driven insights and behavioral interventions
- Scalable platform for multiple chronic conditions
- Direct-to-consumer and enterprise sales channels
Weaknesses
- High marketing and sales expenses
- Reliance on partnerships for distribution
- Competition from larger, more established players
- Cash burn rate
Opportunities
- Expanding partnerships with employers and health plans
- Acquiring new technologies and companies
- Increasing adoption of digital health solutions
- Growing prevalence of chronic diseases
Threats
- Intense competition
- Regulatory changes
- Data privacy concerns
- Reimbursement challenges
- Economic Downturn
Competitors and Market Share
Key Competitors
- TDOC
- LVGO
- OMRON
- ABT
- DXCM
- WW
- TALK
- INVO
Competitive Landscape
DarioHealth faces intense competition from larger, more established players with greater resources and brand recognition. The company needs to differentiate itself through its integrated platform and personalized approach.
Major Acquisitions
UpRight
- Year: 2021
- Acquisition Price (USD millions): 27.8
- Strategic Rationale: Acquisition of UpRight brought in the Musculoskeletal (MSK) market to provide better offerings.
Growth Trajectory and Initiatives
Historical Growth: Illustrative data: DarioHealth has experienced rapid revenue growth in recent years, driven by increased adoption of its platform. However, profitability remains a challenge.
Future Projections: Analysts anticipate continued revenue growth for DarioHealth, driven by expanding partnerships and increasing adoption of digital health solutions. Projected growth will depend on acquisitions and achieving profitability.
Recent Initiatives: DarioHealth has focused on expanding its enterprise sales channel, acquiring new technologies, and developing new solutions for additional chronic conditions.
Summary
DarioHealth is a growing digital health company with a comprehensive platform and a strong focus on personalized interventions. Although it has demonstrated revenue growth, profitability has been a constant challenge. The company needs to overcome competition and efficiently market its products. It needs to scale quickly and efficiently in a rapidly expanding digital health market.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings, investor presentations, industry reports, analyst reports
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Investment decisions should be based on individual research and consultation with a financial professional.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About DarioHealth Corp
Exchange NASDAQ | Headquaters New York, NY, United States | ||
IPO Launch date 2014-10-06 | CEO & Director Mr. Erez Raphael | ||
Sector Healthcare | Industry Health Information Services | Full time employees 196 | Website https://www.dariohealth.com |
Full time employees 196 | Website https://www.dariohealth.com | ||
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.